Abstract
With the advent of the era of knowledge economy and China’s join into WTO, the Problem of intellectual property rights of drug has become increasingly important to Pharmaceutical industry and even to all society. The Patent Protection is the most important part of intellectual property right of drug, which does not only act as a safe guard and stimulator to drug development, but also is a Powerful tool for drug development Providing comprehensive technology and law information. The paper analyzed some Pharmaceutical companies' strategies to develop new drug with Patent. An investigation of the U.S. Federal Trade Commission shows that, the pharmaceutical industry is more dependent on patents than any other industries; the industry prevents free competition, compensate R&D investment, and learn about new technical breakthroughs through patents. Chinese researchers have no strong awareness of using patent literatures, often neglecting acquisition and analysis of patent information. Therefore, the author summarized and analyzed current methods of how foreign pharmaceutical companies use patent information for drug development, to provide Chinese pharmaceutical companies with references on fully using patent resources to develop drugs
Highlights
With the advent of the era of knowledge economy and China’s join into WTO, the Problem of intellectual property rights of drug has become increasingly important to Pharmaceutical industry and even to all society
The patent literature database should be established for internal R&D staff
The companies can prevent the leakage of technology secret during the retrieval in external databases, while ensuring the full utilization of domestic and foreign patent literatures
Summary
Another common strategy of utilizing patents is to look for patent breach or redevelop the patents. By retrieving related literatures of patented drugs, you can find deficiencies in existing patents and transform them to form peripheral patents to achieve cross-licensing. You can redevelop the drugs with expired patents to form new patented drugs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have